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Background: Health care systems initiating major behavioral health programs often face challenges with variable
implementation and uneven patient engagement. One large health care system, Veterans Health Administration
(VHA), recently initiated the MOVE!W Weight Management Program, but it is unclear if veterans most in need of
MOVE!W services are accessing them. The purpose of this study was to examine patient and facility factors
associated with MOVE!W utilization (defined as 1 or more visits) across all VHA facilities.
Methods: Using national administrative data in a retrospective cohort study of eligible overweight (25 < = body mass
index (BMI) < 30 and at least one obesity associated comorbidity) and obese (BMI > =30) VHA outpatients, we examined
variation in and predictors of MOVE!W utilization in fiscal year (FY) 2010 using generalized linear mixed models.
Results: 4.39% (n = 90,230) of all eligible overweight and obese patients using VHA services utilized MOVE!W services at
least once in FY 2010. Facility-level MOVE! Utilization rates ranged from 0.05% to 16%. Veterans were more likely to have
at least one MOVE!W visit if they had a higher BMI, were female, unmarried, younger, a minority, or had a psychiatric or
obesity-related comorbidity.
Conclusions: Although substantial variation exists across VHA facilities in MOVE!W utilization rates, Veterans most in
need of obesity management services were more likely to access MOVE!W, although at a low level. However, there may
still be many Veterans who might benefit but are not accessing these services. More research is needed to examine the
barriers and facilitators of MOVE!W utilization, particularly in facilities with unusually high and low reach.
Keywords: Obesity, Treatment utilization, MOVE!, Obesity management program, VeteransBackground
MOVE!W weight management program utilization across
VA facility
The prevalence of obesity (Body Mass Index (BMI) > 30)
has grown steadily over the past several decades to nearly
34% of the United States population in 2008 [1]. Obesity
increases risk of developing several chronic health condi-
tions, including cardiovascular disease, diabetes, sleep
apnea and other medical conditions [2]. Further, obesity is
linked to reduced quality of life, survival [1,3] and in-
creased healthcare costs [4-6]. The prevalence of obesity
among the 5.5 million patients treated yearly in the* Correspondence: aaron.delre@va.gov
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reproduction in any medium, provided the orVeterans Health Administration (VHA) is similar (35%) to
that of the general U.S. population [2,3,7]. To address the
obesity epidemic in VHA, MOVE!W was developed in 2006
to provide weight loss programs throughout the VHA
health system, based on evidence-based principles and to
provide a multifaceted approach to treating and managing
obesity [8-10]. Veterans are eligible for MOVE!W if they are
obese (BMI ≥30) or overweight (25 ≤ BMI <30) with
obesity-related conditions, younger than age 70, and have
no contraindication to weight loss.
In 2010, just over 30% of obese VHA patients were es-
timated to have received one of the numerous obesity
management interventions available in VHA (e.g., educa-
tion, nutrition counseling, medication) [11] but only 2%
of the total VHA outpatient population (> 5.5 million) had
contact with MOVE!W [12]. It is unclear to what extentLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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erans with obesity-related comorbidities who are at in-
creased risk for adverse events.
Previous research has found that utilization of VHA
obesity management services in 2002 to 2006 (prior to
MOVE!W) was more likely among racial/ethnic minor-
ities, women, younger veterans, and unmarried veterans
[11,13]. Veterans with psychiatric conditions were also
found to use obesity management services at higher rates
if they had obesity-related comorbidities (e.g., diabetes) or
filled obesogenic psychiatric medications in VHA [13].
The current analysis extends these prior studies by exam-
ining use of MOVE!W services in a national population of
veterans in 2010. The purpose of this study was to describe
the facility-level variability in the utilization of MOVE!W
(defined as 1 or more visits) and to examine patient- and
facility-level correlates of MOVE!W use, which can inform
MOVE!W-related quality improvement efforts.Met study inclusion criteria
(BMI >= 30 or 25 <= BMI < 30 
and at least one obesity 
associated comorbidity)
(Final N = 2,054,367)
Figure 1 Flowchart. Legend: Flowchart of reduction in sample at
each data step.Methods
Study design and sample
Using the outpatient VHA Decision Support System
(DSS) database, we conducted a retrospective cohort study
of all veterans from 140 Veterans Affairs Medical Centers
(VAMCs) that offered the MOVE!W program in 2010 that
had at least one available height and weight to calculate
Body Mass Index (BMI). FY2010 was the most recent data
available at the time of analysis. There is no reason to be-
lieve that this particular year is any different in promotion
to clients or providers (or otherwise) than previous or
later years. Of the 5,576,858 total VHA outpatients seen
in fiscal year (FY) 2010 in these 140 facilities, 64% (N =
3,574,765) had at least one height and weight available to
calculate BMI (Figure 1). If there were multiple values per
patient available, the median value was used, among bio-
logically plausible (i.e., height < 84 inches and weight < 700
pounds) values, to calculate BMI. Patients were retained
in the final sample (N=2,054,367) if they had a BMI > = 30
or 25 < = BMI < 30 and at least one obesity associated
comorbidity (e.g., diabetes, hypertension, hyperlipdemia,
heart disease, congestive heart failure, cholelithiasis, osteo-
arthritis, low back pain, gastroesophageal reflux disease,
and obstructive sleep apnea). Note that patients >70 years
of age are not a targeted group for MOVE!W but we chose
to analyze the total population of obese veterans in 2010
to have a more complete understanding of MOVE!W use
among all obese veterans and for greater generalizability.Outcome and explanatory variables
The primary outcome of this study was MOVE!W utilization,
defined as having at least one MOVE!W outpatient visit in
VHA National Patient Care Databases (NPCD) in FY2010
identified using VHA clinic stop codes 372 or 373.VHA stopcodes are included in all outpatient records to signify the
type of clinic or treating specialty.
Several patient characteristics were obtained from the
NPCD including age (categorized as age <40, 40–49, 50–
59, 60–69, 70–79, 80+), gender, marital status (married or
other), minority status (minority or non-minority status),
BMI (defined as [703 × weight in pounds]/ [height in
inches squared]) categorized into 4 levels (overweight =
BMI <30, Class I Obesity = 30–34 BMI, Class II Obesity =
35–40 BMI, and Class III Obesity >40 BMI), home instabil-
ity ("HOMLESS" in NPCD or clinic stop code signifying
homeless or housing services or ICD-9-CM V60 indicat-
ing lack of housing), outpatient copayment status (co-pay
required vs. not), geographic location, obesity diagnosis
(ICD-9-CM 278.00, 278.01, 259.9, V778), obesity-related
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and psychiatric diagnoses.
Copayment status was determined from VHA priority
status, which consists of nine disability and income re-
lated categories. Although MOVE!W is a free service to
all veterans requiring no co-pay, we chose to include this
variable, as it correlates with both illness severity and so-
cioeconomic status [13,14]. Geographic location was classi-
fied into urban, rural, or highly rural location, based on
patients’ zip code following methods described by Kaboli &
Glasgow [15]. Obesity-related comorbidities included dia-
betes (250, 357.2, 362.0, 366.41), hypertension (401–405),
hyperlipdemia (272), heart disease (429.1, 429.0, 429.2,
429.9, 410, 411,412, 413, 414, 440), congestive heart failure
(402, 404.0, 414.19, 425.4, 428, 429.1, 429.4, 997.1), chole-
lithiasis (574), osteoarthritis (715), low back pain (722, 724,
846, 847), gastroesophageal reflux disease (530.11, 530.81,
530.2,787.1), and obstructive sleep apnea (780.57, 786.03,
327.2, 327.20, 327.21, 327.23, 327.29). Obeseogenic psy-
chiatric drug prescriptions included amitriptyline, clomip-
ramine, desipramine, doxepin, imipramine, mirtazapine,
nortriptyline, paroxetine, clozapine, olanzapine, quetiapine,
risperidone, thioridazine, lithium, valproic acid, gabapentin,
and nefazodone. Psychiatric diagnoses included every
major disorder (ICD-9 codes: 294, 295, 296,297.0, 297.1,
298, 300, 301, 306, 307, 309.1, 309.8, 309.9, 310, 311, 313.1,
314.0). See Table 1 for details of the included variables.
In addition, we calculated engagement in "other obesity-
related care" (Current Procedural Terminology codes S94
49, S9451, S9452, S9470, G0270, G0271, 97110, 97113,
97530, 97150, 97802, 97802, 97803, 97804; outpatient
clinic codes 123, 124, 139, 140, 708, 709; weight lossTable 1 Obesity- and psychiatric-related diagnoses
Condition ICD-9-CM diagnosis code
Obesity 278.00, 278.01, 259.9, V778
Diabetes 250, 357.2, 362.0, 366.41
Hypertension 401, 402, 403, 404, 405
Hyperlipdemia 272
Coronary Heart Disease/Ischemic
Heart Disease (includes CAD, MI)
429.1, 429.0, 429.2, 429.9, 410, 411,
412, 413, 414, 440




Low back pain 722, 724, 846, 847
Gastroesophageal reflux disease 530.11, 530.81, 530.2,787.1
Obstructive sleep apnea 780.57, 786.03, 327.2, 327.20, 327.21,
327.23, 327.29
Psychiatric Dx (any) 294, 295, 296,297.0, 297.1, 298, 300,
301, 306, 307, 309.1, 309.8, 309.9,
310, 311, 313.1, 314.0medications orlistat, phentermine and sibutramine; ICD-
9-CM codes 43.89, 44.31, 44.38, 44.39, 44.68, 44.69, 44.95,
44.96, 44.97, 44.98, 45.51, 45.91) which involved any other
obesity care, such as nutritional consultation or bariatric
surgery. However, we found that among patients receiving
MOVE!, 87.03% had received other obesity care. Because
other obesity care is essentially a proxy for our outcome,
including it as a predictor substantially changes the inter-
pretation of the other predictors. Given that our aim was
to predict MOVE! utilization, not MOVE! utilization con-
ditional on having received other obesity care, we did not
include this term in our models at the patient-level.
Facility -level predictors were derived by aggregating
patient characteristics by facility (N = 140) and enabled
examination of the relationship between overall facility
characteristics and MOVE!W utilization. The following
facility characteristics were calculated, based on percent-
age of patients in the facility meeting criteria: facility rates
of male gender, minority status, home instability, outpatient
copay, rural geographic residence, BMI, obesity-related co-
morbidity, obeseogenic psychiatric drug prescription, psy-
chiatric diagnosis, and provisions of other obesity care.
Analytic plan
To describe and explore variability in facility-level rates of
MOVE!W utilization, we calculated the rate of MOVE!W
receipt (number of obese patients who had at least one
MOVE!W visit divided by the total number of obese patients
in the facility) in each of the 140 VHA facilities. Then,
we examined patient factors associated with the binary
patient-level response variable (MOVE!W utilization:
0 = no, 1 = yes), which was estimated using generalized lin-
ear mixed effect models with a random effect for facility
to account for the clustering of patients within VHA facil-
ities. Non-significant variables were trimmed from these
models, resulting in the final multivariate model. The
mixed-effect regression models were conducted using the
GLIMMIX function within the SAS statistical software
(version 9.2) and additional analyses, including graphics
with the ggplot2 package and advanced mixed-effects
modeling procedures with the lme4 package were con-
ducted within the R statistical software (version 3.0.1).
The VA Palo Alto Health Care System’s research office
and Stanford University’s Human Research Protection
Program approved this project.
Results
In FY2010, 4.4% (n = 90,238) of all veterans in the final
analytic sample (N=2,054,367) had at least one MOVE!W
visit, with an average of 4.9 (SD = 8.4, median = 2.0)
MOVE!W visits in 2010 among those with at least one
visit. Within the 140 VHA facilities, the proportion of
patients who received MOVE!W treatment ranged from
0.05% to 16% (mean = 4.4%). Figure 2 graphically depicts
Figure 2 Variability in MOVE! utilization across VA facility. Legend: Displayed is the variability in facility level percentage of patients utilizing
MOVE services. The 140 VA facilities are ordered from smallest to largest percentage and the size of each point represents the number of patients
within each respective facility.
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ordered from smallest to largest on the x-axis (size of
the points represent facility size). Among patients under
70 (n = 1,468,911), who are specifically targeted for
MOVE!W services, 6% (n = 83,140) of all veterans in the
final analytic sample had at least one MOVE!W visit, with
an average of 4.8 (SD = 8.2, median = 2.0) MOVE!W visits
among those with at least one visit.
Unadjusted predictors of MOVE!W utilization
Obese VHA patients were more likely to use MOVE!W one
or more times in FY2010 if they had a higher BMI, were
younger, female, not married, of minority status, had home
instability, or lived in urban areas (Table 2). In addition,
MOVE!W utilization was positively associated with out-
patient copayment status (payment required vs. exempt),
obesity diagnosis, obesity or psychiatric-related comorbidi-
ties, and obeseogenic psychiatric drug prescriptions.
Obese VHA patients treated at facilities with higher pro-
portions of minority patients, home instability, and patients
from urban residence were more likely to utilize MOVE!W
(Table 2). In addition, facilities with a larger proportion of
patients with lower rates of obesity-related comorbidities
and obesogenic psychiatric medication prescriptions had
higher MOVE!W utilization. Facility-level variables thatwere not related to MOVE!W utilization included the
proportion of men, outpatient copayment required, psy-
chiatric diagnoses, and average facility BMI.
Adjusted predictors of MOVE!W utilization
In adjusted analyses (Table 3), veterans were more likely to
use MOVE!W if they had Class III BMI (morbidly obese)
(OR = 4.54 , 95% confidence interval (CI): 4.43, 4.56), were
between 40–69 years old, compared to <40 (OR = 1.21-
1.25), female (OR = 1.66, 95% CI: 1.62, 1.7), not married
(OR = 0.94, 95% CI: 0.93, 0.95), minority status (OR = 1.36,
95% CI: 134, 1.39), home instability (OR = 1.63, 95% CI:
1.57, 1.68), living in urban areas (OR = 1.17, 95% CI: 1.15,
1.19), required to pay outpatient copayments (OR = 1.63,
95% CI: 1.57, 1.68), obesity and psychiatric-related comor-
bidities (OR = 1.68, 95% CI: 1.64, 1.73 and OR= 1.58, 95%
CI: 1.55, 1.60, respectively), and obeseogenic psychiatric
drug prescriptions (OR = 1.17, 95% CI: 1.15, 1.19). Veterans
were less likely to use MOVE!W if they were seen in VA
medical centers with higher rates of home instability (OR =
1.09 95% CI: 1.02, 1.16) and lower rates of obesogenic psy-
chiatric drug prescriptions (OR = 0.92, 95% CI: 0.90, 0.95).
The individual-level fixed effects (predictors) accounted for
20% of the variance in MOVE! utilization (marginal
psuedo-R2). The facility-level fixed-effects (predictors)
Table 2 Patient- and facility-level correlates of MOVE!
utilization among obese patients treated in the veterans
health administration in fiscal year 2010
Patient-level correlates
Total unique patients No MOVE! use 1+ MOVE! visits
(N = 2,054,367) 1,964,129 (95.61%) 90,238 (4.39%)
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Class I (30–34 BMI)*** 44.43% 35.62%
Class II (35–39 BMI)*** 17.14% 26.93%































Male gender [mean (sd)] 93.84 (01.90) 93.87 (01.80)
Minority status*** [mean (sd)] 25.22 (18.41) 24.26 (16.86)
Home instability*** [mean (sd)] 02.26 (01.56) 02.51 (01.80)
Outpatient copay [mean (sd)] 00.18 (0.09) 00.17 (00.09)
Rural location* [mean (sd)] 11.30 (21.16) 09.66 (18.86)
BMI [mean (sd)] 32.78 (0.47) 32.80 (0.39)
Obesity comorbidity**
[mean (sd)]
88.65 (02.67) 88.32 (02.57)
Table 2 Patient- and facility-level correlates of MOVE!
utilization among obese patients treated in the veterans
health administration in fiscal year 2010 (Continued)
Psychiatric Dx [mean (sd)] 21.52 (04.07) 21.44 (03.93)
Obesogenic drugs ***
[mean (sd)]
17.93 (03.10) 17.50 (02.77)
Obesity comorbidity**
[mean (sd)]
88.65 (02.67) 88.32 (02.57)
Note: *p < .05, **p < .01, ***p < .001 in single-predictor, mixed-effects regression
models with a random effect for VA facility. For categorical variables, signifi-
cant differences are between the indicated group and the reference group.
Del Re et al. BMC Health Services Research 2013, 13:511 Page 5 of 8
http://www.biomedcentral.com/1472-6963/13/511accounted for 2% of the variance in MOVE! utilization
(marginal psuedo-R2). An additional 8% of the variance in
MOVE! utilization was explained by between-facility vari-
ability (conditional psuedo-R2).
Discussion
Health care systems initiating major behavioral health pro-
grams often face challenges with variable implementationTable 3 Final model of MOVE! utilization among obese
patients treated in the veterans health administration
(FY 2010) a(N=1,742,937)
OR [95% CI] P
Age (ref.: <40 years old)
40–49 1.21 [ 1.17, 1.25 ] <.001***
50–59 1.25 [ 1.21 , 1.28 ] <.001***
60–69 1.24 [ 1.20 , 1.28 ] <.001***
70–79 0.45 [ 0.44 , 0.47 ] <.001***
80+ 0.18 [ 0.17 , 0.20 ] <.001***
Female gender 1.66 [ 1.62 , 1.70 ] <.001***
Married 0.94 [ 0.93 , 0.95] <.001***
Minority racial status 1.36 [ 1.34 , 1.39 ] <.001***
BMI (ref.: Overwt [<30 BMI])
Class I (30–34 BMI) 1.47 [ 1.44, 1.51] <.001***
Class II (35–39 BMI) 2.67 [ 2.61 , 2.73 ] <.001***
Class III (40+ BMI) 4.54 [ 4.43 , 4.56 ] <.001***
Home instability 1.63 [ 1.57 , 1.68 ] <.001***




Rural 0.95 [ 0.82 , 1.09 ] .46
Urban 1.17 [ 1.15 , 1.19] .02*
Obesity comorbidity 1.68 [ 1.64 , 1.73 ] <.001***
Obesogenic psychiatric drug 1.17 [ 1.15 , 1.19 ] <.001***
Psychiatric diagnosis 1.58 [ 1.55 , 1.60 ] <.001***
% Home instability 1.09 [ 1.02 , 1.16 ] <.001***
% Obesogenic drugs 0.92 [ 0.90 , 0.95 ] <.001***
Intercept 0.03 [ 0.02, 0.06 ] <.001***
Note: aResults from mixed-effects logistic regression model with a random ef-
fect for facility. *p < .05, ***p < .001.
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that predict both patient engagement and facility variability
in utilization can help focus subsequent quality improve-
ment efforts. This study examined patient and facility char-
acteristics associated with MOVE!W utilization among
obese VHA outpatients in 2010. Among the almost 2.5
million VHA patients meeting criteria for obesity from
140 VA facilities in 2010, 4.4% had at least one MOVE!W
visit. Among patients younger than 70 to whom MOVE!W
is targeted, 6% had at least one MOVE!W visit. Of note is
that Office of Quality and Performance (OQP) chart re-
view process found that 10% of "at-risk" Veterans had uti-
lized MOVE!W in 2010 [8], which is a considerably higher
rate than was found here. The chart review procedure
used by OQP typically involves taking a relatively small
sample of patient records and thoroughly examining clinic
notes related to inpatient or outpatient visits. While chart
review may be more sensitive than administrative data for
identifying MOVE!W visits, the estimates from small sam-
ple chart review can be highly variable. In contrast, al-
though administrative data utilized in this study may miss
some MOVE! visits, the estimates of use have much tigh-
ter confidence intervals due to the very large sample size.
Perhaps more interesting and important than the over-
all utilization rate is the large variation in use across
VHA facilities (ranging .05% to 16%). These data show
that some facilities manage to provide MOVE!W services
to nearly 4 times the national average in terms of pro-
portion of patients served. In addition, this finding sug-
gests that many facilities could dramatically increase the
proportion of obese patients receiving these services.
More research is needed to examine the barriers and fa-
cilitators of MOVE!W utilization, particularly in facilities
with unusually high and low reach. Also, increasing
the number of visit per patient is an important quality
improvement goal since prior work has shown that hav-
ing two or more MOVE!W visits is associated with at
least a 5% weight loss [8].
Patient characteristics
It is certainly promising that veterans with higher BMI,
obesity-related comorbidities, and obesogenic drug pre-
scriptions had greater MOVE!W utilization because this
suggests that veterans most in need of MOVE!W obesity
management services were accessing MOVE!W at higher,
albeit still suboptimal, rates. Unexpected patient-level pre-
dictors of MOVE!W utilization included home instability
and having a required outpatient copayment. Greater
MOVE!W utilization among patients with home instability
may be encouraged by their VA providers to use MOVE!W
outpatient services as a part of their treatment plans.
The positive association with MOVE!W use and required
outpatient copayment may be due to the fact that MOVE!W
services are offered to all Veterans at no cost due to copayexemption or waiver of copays in June 2008 [18]. Having a
copayment requirement may be a proxy for higher
socioeconomic status and less illness severity because VA
requires veterans to pay copayments if they have limited
military-service related disability or higher incomes.
Patients between 40–69 years-old were more likely to
utilize MOVE!W services. After age 69, there is a substantial
decline in MOVE!W utilization, which may be due to the
target of screening for referral (i.e., automated clinic re-
minders) to MOVE!W services are those obese patient
younger than 70 for whom weight management are clear.
A sensitivity analysis that restricted the sample to patients
younger than 70 found a MOVE!W utilization rate of 6%
(versus 4.4% for the entire sample of obese patients), but
the coefficients for the other predictors remained nearly
unchanged.
The positive association between MOVE!W utilization
and urban geographic location is consistent with previous
obesity management literature [8] and health services uti-
lization (generally) [19]. Veterans living further away from
the VHA hospital are less likely to attend the program,
due to proximity-related barriers.Facility-level predictors
After accounting for several patient-level predictors in a
multi-predictor mixed effects regression, some specific fa-
cility factors related to treatment context or casemix were
associated with receipt of at least one MOVE!W visit. Vet-
erans at facilities with higher proportion of patients with
home instability and lower obesogenic drug prescriptions
rates were more likely to access MOVE!W Regarding the
positive relationship between facility-level proportion of
home instability and MOVE!W use, perhaps (and similar to
the individual-level relationship) there is greater facility-
wide emphasis on having providers encourage their obese
patients to use MOVE!W outpatient services as a part of
their treatment plans. However, although statistically sig-
nificant, these findings may be less clinically relevant. That
is, the overall differences in MOVE! utilization by facility-
level characteristics were small (accounted for 2% of vari-
ability in MOVE! use) but the sample size was large
enough to detect statistical differences.Limitations
This study has several limitations, including a cross-
sectional observational study design that was limited to
patients’ treated in the VHA in FY2010, which limits
causal interpretation of findings and may not generalize
to earlier or later years. Another limitation is that the
number of MOVE!W visits was not examined, which may
result in very different findings from that of utilization
based on at least 1 MOVE!W visit. Finally, there were sev-
eral unmeasured variables, such as differential resource
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MOVE!W utilization that could bias these results.
Despite these limitations, this study had several strengths.
Over 2 million patients treated across 140 VHA hospitals
nationwide in 2010 were included in this analysis. To our
knowledge, this is the largest obesity management study
conducted to date. Substantial variation in MOVE!W utili-
zation across facilities was found and several patient- and
facility-level factors were associated with this variation.
Although MOVE!W utilization is modest for obese Vet-
erans, those who are in most need of this obesity manage-
ment service (i.e., patients’ diagnosed with obesity and
obesity-related comorbidities) are more likely to access
them (albeit at a low level). However, there may still many
Veterans in need who are not accessing these services. The
findings from this study suggest that reducing barriers to
MOVE! utilization for these patients is an important next
step in disseminating MOVE!W further.Conclusion
The results from this study suggest that veterans most in
need of obesity management services are more likely to ac-
cess MOVE!W (albeit at low levels). However, substantial
variation exists across VHA facilities in utilization rates and
much of the variability in utilization remains unexplained.
Tailored outreach and patient-education materials might
target groups under-served by MOVE!W, including rural
veterans and less obese veterans. In addition, determining
ways to increase access and utilization of MOVE!W is an ob-
vious implementation challenge. Provision of tele-based or
web-based MOVE!W could improve access, and VA is cur-
rently developing these modalities. Further research exam-
ining lower rates of MOVE!W utilization among men and
those patients’ living in rural communities is needed to
guide development of interventions to improve MOVE!W
receipt. Although our focus was to predict overall MOVE!W
utilization, another related area we did not address was pre-
dictors of MOVE!W utilization conditional on having re-
ceived other obesity care. The predictors of a model
including that term answers a different question: What are
the predictors of MOVE!W above and beyond the variance
explained by receipt of other obesity care in general? Given
the high overlap of MOVE!W and other obesity care, this
latter question would be better addressed by restricting the
analysis to patients who receive some obesity care of any
kind. Although the focus of this study was on VHA, these
results may apply to other health care systems that are
initiating similar programs.Competing interests
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